Nanoparticle delivery of a peptide targeting EGFR signaling

Journal of Controlled Release

Volumn 157, Issue 2, 2012, Pages 279-286

  Kim, Sang Kyoon ^a   Huang, Leaf ^a  

^a University of North Carolina   (United States)

Author keywords

Drug delivery; Intracellular peptide; Liposome; Nanoparticle; PEGylation

Indexed keywords

CANCER THERAPY; DOMINANT NEGATIVE; DOSE-DEPENDENT MANNER; EGFR SIGNALING; HUMAN CANCER CELLS; HUMAN LUNG CANCER CELLS; INTRAVENOUS ADMINISTRATION; LIPID CARRIERS; MASSIVE APOPTOSIS; MOUSE MODELS; MULTIPLE INJECTIONS; OVER-EXPRESSION; PEGYLATION; PEPTIDE DELIVERY; PEPTIDE-BASED THERAPIES; PROOF OF CONCEPT; PROTEIN-PROTEIN INTERACTIONS; RETICULOENDOTHELIAL SYSTEMS; SIGMA RECEPTORS; THERAPEUTIC TARGETS; TUMOR CELLS; TUMOR GROWTH;

CELL DEATH; CELL PROLIFERATION; DISEASES; DRUG DELIVERY; GLYCOLS; LIPOSOMES; NANOPARTICLES; PHOSPHORYLATION; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; SURFACE STRUCTURE; TUMORS;

PEPTIDES;

ANTINEOPLASTIC AGENT; EEEEPYFELV PEPTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; MACROGOL; NANOPARTICLE; NONAPEPTIDE; PROTEIN INHIBITOR; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; INTRACELLULAR TRANSPORT; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RETICULOENDOTHELIAL SYSTEM; TARGET CELL;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG CARRIERS; FEMALE; HEPARIN; HUMANS; LIPOSOMES; MICE; MICE, NUDE; MOLECULAR TARGETED THERAPY; NANOPARTICLES; NEOPLASMS; OLIGOPEPTIDES; PHOSPHORYLATION; PROTAMINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84855766402     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.08.014     Document Type: Article

References (41)

1. J.B. Gibbs Mechanism-based target identification and drug discovery in cancer research Science 287 2000 1969 1973 (Pubitemid 30158664)
2. J.B. Gibbs, and A. Oliff Pharmaceutical research in molecular oncology Cell 79 1994 193 198 (Pubitemid 24324910)
3. R.R. Poondra, N.N. Kumar, K. Bijian, M. Prakesch, V. Campagna-Slater, A. Reayi, P.T. Reddy, A. Choudhry, M.L. Barnes, D.M. Leek, M. Daroszewska, C. Lougheed, B. Xu, M. Schapira, M.A. Alaoui-Jamali, and P. Arya Discovery of indoline-based, natural-product-like compounds as probes of focal adhesion kinase signaling pathways J. Comb. Chem. 11 1994 303 309
4. K.A. Chester, and R.E. Hawkins Clinical issues in antibody design Trends. Biotechnol. 13 1995 294 300
5. R.C. Ladner, A.K. Sato, J. Gorzelany, and M. de Souza Phage display-derived peptides as therapeutic alternatives to antibodies Drug Discovery Today 9 2004 525 529 (Pubitemid 38739333)
6. J. Brugnano, B.C. Ward, and A. Panitch Cell penetrating peptides can exert biological activity: a review BioMol Concepts 1 2010 109 116
7. M. Zorko, and U. Langel Cell-penetrating peptides: mechanism and kinetics of cargo delivery Adv. Drug Delivery Rev. 57 2005 529 545 (Pubitemid 40255559)
8. N.R. Soman, S.L. Baldwin, G. Hu, J.N. Marsh, G.M. Lanza, J.E. Heuser, J.M. Arbeit, S.A. Wickline, and P.H. Schlesinger Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth J. Clin. Invest. 119 2009 2830 2842
9. L. Yang, F. Cui, K. Shi, D. Cun, and R. Wang Design of high payload PLGA nanoparticles containing melittin/sodium dodecyl sulfate complex by the hydrophobic ion-pairing technique Drug. Dev. Ind. Pharm. 35 8 2009 959 968
10. T. Schluep, P. Gunawan, L. Ma, G.S. Jensen, J. Duringer, S. Hinton, W. Richter, and J. Hwang Polymeric tubulysin-peptide nanoparticles with potent antitumor activity Clin. Cancer. Res. 181 2009 181 189
11. J.S. Wei, H.B. Zeng, S.Q. Liu, X.G. Wang, E.H. Tay, and Y.Y. Yang Temperatureand pH-sensitive core-shell nanoparticles self-assembled from poly(N-isopropylacrylamide-co-acrylic acid-co-cholesteryl acrylate) for intracellular delivery of anticancer drugs Front. Biosci. 10 2005 3058 3067
12. A. Tkachenko, H. Xie, S. Franzen, and D.L. Feldheim Assembly and characterization of biomolecule-gold nanoparticle conjugates and their use in intracellular imaging Methods Mol. Biol. 303 2005 85 99
13. J. Panyam, and V. Labhasetwar Targeting intracellular targets Curr. Drug. Delivery 1 2004 235 247
14. C.L. Duvall, A.J. Convertine, D.S. Benoit, A.S. Hoffman, and P.S. Stayton Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer Mol. Pharm. 7 2010 468 476
15. D. Shenoy, W. Fu, J. Li, C. Crasto, G. Jones, C. DiMarzio, S. Sridhar, and M. Amiji Surface functionalization of gold nanoparticles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and delivery Int. J. Nanomedicine 1 2006 51 57
16. S.D. Li, and L. Huang Surface-modified LPD nanoparticles for tumor targeting Ann. NY. Acad. Sci. 1082 2006 1 8 (Pubitemid 44955442)
17. S.D. Li, and L. Huang Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells Mol. Pharm. 3 2006 579 588 (Pubitemid 44639135)
18. F.M. Johnson, B. Saigal, H. Tran, and N.J. Donato Abrogation of signal transducer and activator of transcription 3 reactivation after Src kinase inhibition results in synergistic antitumor effects Clin. Cancer Res. 17 2007 4233
19. M.T. Kloth, K.K. Laughlin, J.S. Biscardi, J.L. Boerner, S.J. Parsons, and C.M. Silva STAT5b, a mediator of synergism between c-Src and the epidermal growth factor receptor J. Biol. Chem. 278 2003 1671 1679 (Pubitemid 36801399)
20. J.E. Darnell Jr., I.M. Kerr, and G.R. Stark Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421 (Pubitemid 24217131)
21. C.P. Lim, and X. Cao Structure, function, and regulation of STAT proteins Mol. Biosyst. 2 2006 536 550 (Pubitemid 44583902)
22. T.J. Ahonen, J. Xie, M.J. LeBaron, J. Zhu, M. Nurmi, K. Alanen, H. Rui, and M.T. Nevalainen Inhibition of transcription factor STAT5 induces cell death of human prostate cancer cells J. Biol. Chem. 278 2003 27287 27292 (Pubitemid 36876886)
23. C.P. Shelburne, M.E. McCoy, R. Piekorz, V. Sexl, K.H. Roh, S.M. Jacobs-Helber, S.R. Gillespie, D.P. Bailey, P. Mirmonsef, M.N. Mann, M. Kashyap, H.V. Wright, H.J. Chong, L.A. Bouton, B. Barnstein, C.D. Ramirez, K.D. Bunting, S. Sawyer, C.S. Lantz, and J.J. Ryan STAT5 expression is critical for mast cell development and survival Blood 102 2003 1290 1297 (Pubitemid 36988035)
24. F. Debierre-Grockiego Anti-apoptotic role of STAT5 in haematopoietic cells and in the pathogenesis of malignancies Apoptosis 9 2004 717 728 (Pubitemid 40941200)
25. S.D. Li, Y.C. Chen, M.J. Hackett, and L. Huang Tumor-targeted delivery of siRNA by self-assembled nanoparticles Mol. Ther. 16 2008 163 169
26. C. Cande, F. Cecconi, P. Dessen, and G. Kroemer Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J. Cell Sci. 115 2002 4727 4734 (Pubitemid 36054627)
27. J.S. Wadia, and S.F. Dowdy Protein transduction technology Curr. Opin. Biotechnol. 13 1994 52 56
28. J. Gariépy, and K. Kawamura Vectorial delivery of macromolecules into cells using peptide-based vehicles Trends. Biotechnol. 19 2000 21 26
29. M.C. Morris, L. Chaloin, F. Heitz, and G. Divita Translocating peptides and proteins and their use for gene delivery Curr. Opin. Biotechnol. 11 2000 461 466
30. N.J. de Mol, M.I. Catalina, F.J. Dekker, M.J. Fischer, A.J. Heck, and R.M. Liskamp Protein flexibility and ligand rigidity: a thermodynamic and kinetic study of ITAM-based ligand binding to Syk tandem SH2 Chem. Bio. Chem. 6 2005 2261 2270
31. F.J. Dekker, N.J. Mol, M.J.E. de Fischer, and R.M.J. Liskamp Amino propynyl benzoic acid building block in rigid spacers of divalent ligands binding to the Syk SH2 domains with equally high affinity as the natural ligand Bioorg. Med. Chem. Lett. 13 2003 1241 1244 (Pubitemid 36351325)
32. D. Needham, and D.H. Kim PEG-covered lipid surfaces: bilayers and monolayers Colloid Surf B: Biointerfaces 18 2000 183 195 (Pubitemid 30479862)
33. S.D. Li, and L. Huang Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting J. Control. Release 145 3 2010 178 181
34. S.D. Li, and L. Huang Nanoparticles evading the reticuloendothelial system: role of the supported bilayer Biochim. Biophys. Acta, Biomembr. 1788 2009 2259 2266
35. Y.C. Tseng, and L. Huang Self-assembled lipid nanomedicines for siRNA tumor targeting J. Biomed. Nanotechnol. 5 4 2009 Aug 351 363
36. Y. Liu, and L. Huang In vivo delivery of RNAi with lipid-based nanoparticles Annual Review of Biomedical Engineering vol. 13 2011 (Volume publication date August 2011)
37. Q.C. Liang, H. Xiong, Z.W. Zhao, D. Jia, W.X. Li, H.Z. Qin, J.P. Deng, L. Gao, H. Zhang, and G.D. Gao Inhibition of transcription factor STAT5b suppresses proliferation, induces G1 cell cycle arrest and reduces tumor cell invasion in human glioblastoma multiforme cells Cancer Lett. 273 2009 164 171
38. H. Xiong, W.Y. Su, Q.C. Liang, Z.G. Zhang, H.M. Chen, W. Du, Y.X. Che, and J.Y. Fang Inhibition of STAT5 induces G1 cell cycle arrest and reduces tumor cell invasion in human colorectal cancer cells Lab. Investig. 89 2009 717 725
39. I. Matte, D. Lane, E. Côté, A.E. Asselin, L.C. Fortier, C. Asselin, and A. Piché Anti-apoptotic proteins Bcl-2/Bcl-XL inhibit Clostridium difficile toxin A-induced cell death in human epithelial cells Infect. Immun. 77 2009 5400 5410
40. L.H. Boise, M. González-García, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nuñez, and C.B. Thompson bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death Cell 74 1993 597 608 (Pubitemid 23259741)
41. J. Can, and C.R. John Yeast and apoptosis Nat. Rev. Mol. Cell Biol. 3 2002 453 459